Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age
- 1 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (9) , 794-798
- https://doi.org/10.1097/01.inf.0000083824.15218.de
Abstract
We previously investigated antibody titers against four kinds of superantigens [streptococcal pyrogenic exotoxin A (SPEA), streptococcal pyrogenic exotoxin C, toxic shock syndrome toxin-1 and staphylococcal enterotoxin B] in patients with Kawasaki syndrome (KS) younger than 6 months of age and reported a relationship between toxic shock syndrome toxin-1 and KS patients. In this study we have investigated antibody titers in KS patients older than 6 months of age. Serum of 81 patients with KS older than 6 months of age, before intravenous gamma-globulin therapy, and 88 normal age-matched children were used in this study. The IgG antibody titers against four kinds of superantigens were measured with an enzyme-linked immunosorbent assay. The KS patients showed significantly elevated mean SPEA titer (P = 0.006) and significantly higher incidence of high SPEA (P = 0.0024) compared with the controls. The SPEA titer in KS patients showed a significant positive correlation with the number of days from onset of illness (P = 0.0002). The elevated antibody titer against superantigens of KS patients older than 6 months of age was different from that of KS patients younger than 6 months of age. Our results suggest that KS patients' exposure to SPEA occurred a few weeks before the onset of KS. SPEA may be one of the possible etiologic agents of KS among patients older than 6 months of age in Kagoshima, Japan.Keywords
This publication has 14 references indexed in Scilit:
- Prevalence of superantigen-secreting bacteria in patients with Kawasaki diseaseThe Journal of Pediatrics, 2002
- Maternal Antibody against Toxic Shock Syndrome Toxin–1 May Protect Infants Younger than 6 Months of Age from Developing Kawasaki SyndromeThe Journal of Infectious Diseases, 2002
- Superantigens, conventional antigens and the etiology of Kawasaki syndromeThe Pediatric Infectious Disease Journal, 2000
- Polyclonal expansion of TCRBV2‐ and TCRBV6‐bearing T cells in patients with Kawasaki diseaseImmunology, 1999
- Selective Increase of Vβ2+ T Cells in the Small Intestinal Mucosa in Kawasaki DiseasePediatric Research, 1996
- Evidence for a superantigen mediated process in Kawasaki disease.Archives of Disease in Childhood, 1995
- Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-α) by Vβ2− or Vβ8− CD4+ T helper cellsClinical and Experimental Immunology, 1995
- Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndromeThe Lancet, 1993
- Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.Proceedings of the National Academy of Sciences, 1992
- Detection of Serum Antibody by the Antimitogen Assay against Streptococcal Erythrogenic Toxins. Age Distribution in Children and the Relation to Kawasaki DiseasePediatric Research, 1990